Attorneys See Uncertainty in FDA's Implementation of Biosimilar Approvals, Life Sciences Law & Industry Report
by: Life Sciences Law & Industry Report
-
date:
05/28/2010 -
news source:
Morgan Lewis In the News
Morgan Lewis partner Kathleen Sanzo discusses the use of traditional biologics license application (BLA) versus the new biosimilars pathway provided for in the healthcare reform law at the May 20 Washington Legal Foundation media briefing.
Read the article on Life Sciences Law & Industry's website.
Copyright © 2010 by Morgan, Lewis & Bockius LLP. All Rights Reserved.